Mike Matson
Stock Analyst at Needham
(3.09)
# 1,148
Out of 5,172 analysts
561
Total ratings
41.28%
Success rate
0.93%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterates: Buy | $97 | $69.48 | +39.61% | 36 | Mar 20, 2026 | |
| MDT Medtronic | Reiterates: Buy | $120 | $86.16 | +39.28% | 24 | Mar 10, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $26 → $30 | $16.52 | +81.60% | 25 | Feb 27, 2026 | |
| PSNL Personalis | Maintains: Buy | $10 → $12 | $7.26 | +65.29% | 22 | Feb 27, 2026 | |
| VCYT Veracyte | Maintains: Buy | $44 → $48 | $31.84 | +50.75% | 19 | Feb 26, 2026 | |
| ENOV Enovis | Maintains: Buy | $49 → $52 | $21.85 | +137.99% | 17 | Feb 26, 2026 | |
| TFX Teleflex | Maintains: Buy | $138 → $147 | $105.41 | +39.46% | 11 | Feb 26, 2026 | |
| LIVN LivaNova | Maintains: Buy | $64 → $81 | $62.19 | +30.25% | 28 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Buy | $108 → $101 | $66.71 | +51.40% | 33 | Feb 25, 2026 | |
| TMDX TransMedics Group | Maintains: Buy | $166 → $174 | $113.90 | +52.77% | 15 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $86 | $62.65 | +37.27% | 7 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $7.96 | +88.44% | 29 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $29.18 | +54.24% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $87.87 | - | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $58 | $35.31 | +64.26% | 21 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $448 → $454 | $335.67 | +35.25% | 11 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $35.94 | - | 26 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $335.85 | - | 14 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $58.58 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.25 | +140.00% | 22 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $4.22 | +113.27% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $75.41 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $13.53 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.10 | +96.72% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $178.24 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $125.36 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $220.03 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $225.99 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $12.79 | +228.38% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $86.26 | -13.05% | 1 | Feb 18, 2021 |
Boston Scientific
Mar 20, 2026
Reiterates: Buy
Price Target: $97
Current: $69.48
Upside: +39.61%
Medtronic
Mar 10, 2026
Reiterates: Buy
Price Target: $120
Current: $86.16
Upside: +39.28%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $26 → $30
Current: $16.52
Upside: +81.60%
Personalis
Feb 27, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $7.26
Upside: +65.29%
Veracyte
Feb 26, 2026
Maintains: Buy
Price Target: $44 → $48
Current: $31.84
Upside: +50.75%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $21.85
Upside: +137.99%
Teleflex
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $147
Current: $105.41
Upside: +39.46%
LivaNova
Feb 25, 2026
Maintains: Buy
Price Target: $64 → $81
Current: $62.19
Upside: +30.25%
Merit Medical Systems
Feb 25, 2026
Maintains: Buy
Price Target: $108 → $101
Current: $66.71
Upside: +51.40%
TransMedics Group
Feb 25, 2026
Maintains: Buy
Price Target: $166 → $174
Current: $113.90
Upside: +52.77%
Feb 24, 2026
Maintains: Buy
Price Target: $84 → $86
Current: $62.65
Upside: +37.27%
Feb 17, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $7.96
Upside: +88.44%
Feb 12, 2026
Reiterates: Buy
Price Target: $45
Current: $29.18
Upside: +54.24%
Feb 10, 2026
Reiterates: Hold
Price Target: n/a
Current: $87.87
Upside: -
Feb 2, 2026
Reiterates: Buy
Price Target: $58
Current: $35.31
Upside: +64.26%
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $335.67
Upside: +35.25%
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $35.94
Upside: -
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $335.85
Upside: -
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $58.58
Upside: -
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $4.22
Upside: +113.27%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $75.41
Upside: -
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $13.53
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.10
Upside: +96.72%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $178.24
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $125.36
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $220.03
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $225.99
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $12.79
Upside: +228.38%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $86.26
Upside: -13.05%